Live AstraZeneca updates | Page 3

Live AstraZeneca news coverage of developments with the latest updates. Stay on top of latest AstraZeneca news stories and find out what just happened, what is going on with AstraZeneca. The latest real-time news updates and headlines on AstraZeneca
PACIFIC-2 Trial: Imfinzi, Chemoradiotherapy Tested on Stage III Lung Cancer
Research Uncovers Why Lupus is More Prevalent in Women
TIMI Study: Novel Anti-Clot Drug Cuts Bleeding in A-Fib Patients
Single Dose of New Therapy Cuts Heart Disease Risk by 94%
Imfinzi and Bevacizumab Hit Endpoint in Liver Cancer Trial
9M and Q3 2023 results
NHS Drug Repurposed to Prevent Breast Cancer in Thousands of Women
Zibotentan/Dapagliflozin Mix Cuts Albuminuria in ZENITH-CKD Trial
Metabolite Dictates DNA Repair in Cells
ZORA Evidence: Lokelma Boosts RAASi Therapy Success in Cardiorenal Patients
AstraZeneca, Cellectis Ally to Boost Cell Therapy, Genomic Medicine
'Study: Immune Confusion Triggers Severe Dengue in Kids'
Preparing for Potential Thunderstorm Asthma in SE Australia
Antibody-Drug Conjugate Extends Lives in Lung Cancer Fight
UK Chief Scientific Adviser Tours Japan, Korea
FDA Reviews AstraZeneca's Self-Admin FluMist Quadrivalent App
Phase III Trial: Datopotamab Deruxtecan Boosts Survival in Lung Cancer
DESTINY-PanTumor02: Enhertu Shows Promising Survival in HER2+ Tumours
Phase III Trial: Datopotamab Deruxtecan Outperforms Chemo in Breast Cancer
Pre/Post-Surgery Immunotherapy Boosts Lung Cancer Outcomes
EU Approves Enhertu, First HER2-Directed Therapy for Advanced NSCLC
Australia's Long COVID Response: Shortfall in Support
Datopotamab Deruxtecan, Imfinzi Show Strong Results in BEGONIA Trial
Imfinzi and Lynparza Cut Advanced Endometrial Cancer Risk by 45%
Tagrisso and Chemo Cut Brain Disease Risk by 42% in Lung Cancer Patients
Imfinzi Boosts Response Rate in Early-Stage Stomach Cancers
China Approves Soliris for Adult NMOSD Treatment
Tagrisso, Chemotherapy Combo Gets US Priority Review for Advanced Lung Cancer
AstraZeneca Funds Eight Global Early-Career Scientists in R&D Challenge
Gene Findings May Ward Off Lethal Coronary Artery Disease
AstraZeneca Vows to Shield Vulnerable From Infections at IDWeek 2023
Alexion Reveals C5 Inhibition Impact on NMOSD at MSMilan2023
AstraZeneca Reveals Key Findings from Phase III Cancer Trials at ESMO
£5m awarded for Industrial Biotechnology innovation
Pan-Cancer Biomarker Detected by Ultrasensitive Blood Test
Health Professional & Industry Roundtable
Unconventional Vaccine Thwarts Superbugs Including MRSA
Could Single Vaccine Conquer All Hospital Superbugs?
AstraZeneca Study Links Rare Gene Changes to Protein Levels in Drug Discovery Breakthrough
Forxiga Hits Primary Endpoint in Major Pediatric Diabetes Trial
New Gene Discoveries May Prevent Fatal Coronary Disease
Biden's Major Move to Slash Health Care Costs: Drug Price Talks
AstraZeneca Resolves Nexium, Prilosec Liability Disputes
Phase III Trial: Datopotamab Deruxtecan Shows Significant Benefit in Breast Cancer
Alexion Acquires Rare Disease Gene Therapy Portfolio from Pfizer
Oral Health Woes May Lower Head, Neck Cancer Survival
Broken String Biosciences closes $15m funding round
Oxford, Liverpool Scientists Initiate MERS Vaccine Trial